Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1986-9-16
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0019-509X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
33-7
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:3939232-Adenocarcinoma,
pubmed-meshheading:3939232-Adult,
pubmed-meshheading:3939232-Cystadenocarcinoma,
pubmed-meshheading:3939232-Female,
pubmed-meshheading:3939232-Humans,
pubmed-meshheading:3939232-Middle Aged,
pubmed-meshheading:3939232-Ovarian Neoplasms,
pubmed-meshheading:3939232-Thiotepa
|
pubmed:year |
1985
|
pubmed:articleTitle |
High dose thiotepa in ovarian cancer.
|
pubmed:publicationType |
Journal Article,
Case Reports
|